Latest Charles A. Dinarello Stories
DENVER, Feb. 24, 2011 /PRNewswire/ -- (OTC Bulletin Board: OMBP): Omni Bio Pharmaceutical, Inc. ("Omni Bio") today announced that effective March 1, 2011, Dr. James Crapo will become its Chief Executive Officer. The board of directors of the Company anticipates appointing Dr.
DENVER, Jan. 4, 2011 /PRNewswire/ -- Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTC Bulletin Board: OMBP), today announced that U.S. Patent No.
A husband and wife research team from Melbourne, Australia, have identified a protein that may be a key therapy for many inflammatory diseases, including those affecting premature babies.
MINNEAPOLIS, June 10 /PRNewswire-FirstCall/ -- Charles A. Dinarello, M.D., a Professor of Medicine at the University of Colorado School of Medicine in Denver and a member of the Techne Corporation Board of Directors, was recently recognized with two distinguished awards. On April 26, 2009, Dr.
BERKELEY, Calif., Sept. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that the company will host a live web cast of its analyst and investor event on September 25, 2008 at 5:00 PM Eastern.
- The act of sweetening by admixture of some saccharine substance.